YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis

dc.authorwosid Alacacioglu, Ahmet/W-1557-2017
dc.authorwosid Sendur, Mehmet/H-7555-2014
dc.authorwosid Harputluoglu, Hakan/Abi-6451-2020
dc.authorwosid Cicin, Irfan/Aaq-5575-2020
dc.authorwosid Bilir, Cemil/A-2491-2017
dc.authorwosid Geredeli, Caglayan/Aan-4122-2020
dc.contributor.author Isikdogan, A.
dc.contributor.author Turk, H.
dc.contributor.author Bilir, C.
dc.contributor.author Sendur, M.
dc.contributor.author Karabulut, B.
dc.contributor.author Artac, M.
dc.contributor.author Yalcin, S.
dc.date.accessioned 2025-05-10T17:37:00Z
dc.date.available 2025-05-10T17:37:00Z
dc.date.issued 2022
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Isikdogan, A.] Dicle Univ Hosp, Diyarbakir, Turkey; [Turk, H.] Bezmialem Vakif Univ Hosp, Istanbul, Turkey; [Bilir, C.] Sakarya Univ, Med Sch, Sakarya, Turkey; [Sendur, M.] Ankara Yildirim Beyazit Univ, Fac Med, Ankara, Turkey; [Sendur, M.] Ankara City Hosp, Ankara, Turkey; [Karabulut, B.] Ege Univ, Tulay Aktas Oncol Hosp, Izmir, Turkey; [Artac, M.] Necmettin Erbakan Univ, Meram Med Sch, Konya, Turkey; [Cicin, I.] Trakya Univ, Sch Med, Edirne, Turkey; [Geredeli, C.] SBU, Cemil Tascioglu Sehir Hosp, Istanbul, Turkey; [Alacacioglu, A.] Katip Celebi Univ, Ataturk Res & Training Hosp, Izmir, Turkey; [Kefeli, U.] Kocaeli Univ, Sch Med, Kocaeli, Turkey; [Harputluoglu, H.] Inonu Univ, Turgut Ozal Med Ctr, Malatya, Turkey; [Bozkurt, O.] Erciyes Univ, Sch Med, Kayseri, Turkey; [Cubukcu, E.] Uludag Univ Hosp, Bursa, Turkey; [Tural, D.] SBU, Bakirkoy Sadi Konuk Hosp, Istanbul, Turkey; [Sakin, A.] Yuzuncu Yil Univ Hosp, Istanbul Fatih, Turkey; [Cil, T.] SBU, Adana SUAM, Adana, Turkey; [Dane, F.] Marmara Univ, Istanbul, Turkey; [Cevik, D.] Amgen Turkey, Istanbul, Turkey; [Arslan, C.] Izmir Econ Univ, Medicalpk Hosp, Izmir, Turkey; [Karadurmus, N.] SBU, Gulhane Med Fac, Ankara, Turkey; [Gumus, M.] Istanbul Medeniyet Univ, Goztepe Prof Dr Suleyman Yalcin City Hosp, Istanbul, Turkey; [Yalcin, S.] Hacettepe Univ, Ankara, Turkey en_US
dc.description.sponsorship Amgen en_US
dc.description.sponsorship Amgen. en_US
dc.description.woscitationindex Science Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.doi 10.1016/j.annonc.2022.04.180
dc.identifier.endpage S281 en_US
dc.identifier.issn 0923-7534
dc.identifier.issn 1569-8041
dc.identifier.scopusquality Q1
dc.identifier.startpage S281 en_US
dc.identifier.uri https://doi.org/10.1016/j.annonc.2022.04.180
dc.identifier.uri https://hdl.handle.net/20.500.14720/14241
dc.identifier.volume 33 en_US
dc.identifier.wos WOS:000823826500103
dc.identifier.wosquality Q1
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartof ESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN en_US
dc.relation.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis en_US
dc.type Conference Object en_US

Files